Previous studies have reported that nuclear β‐catenin could bind and activate transcriptional factors, enhancing the metastatic potential of cancer cells.[29, 30] Whether TTK‐induced β‐catenin nuclear accumulation regulates phenotypic switching of VSMCs through other pathways needs to be further examined. The gene discussed is TTK; the disease is cancer.